Peer-reviewed veterinary case report
2016 AAFP Guidelines for the Management of Feline Hyperthyroidism.
- Journal:
- Journal of feline medicine and surgery
- Year:
- 2016
- Authors:
- Carney, Hazel C et al.
- Affiliation:
- WestVet Emergency and Specialty Center · United States
- Species:
- cat
Plain-English summary
Feline hyperthyroidism is a condition that affects older cats, and our understanding of it has improved significantly since it was first reported in the late 1970s. Now, veterinarians can diagnose it earlier through routine blood tests, which helps catch the disease before cats show severe symptoms like weight loss and agitation. The 2016 guidelines provide clear recommendations for how to manage this condition, including when to start treatment and how to handle other health issues that might be present at the same time, like kidney or heart disease. They emphasize that all cats with hyperthyroidism should receive treatment, regardless of other health problems, and offer strategies for monitoring their health after treatment. Overall, these guidelines aim to help veterinarians provide better care and improve outcomes for affected cats.
Abstract
CLINICAL CONTEXT: Since 1979 and 1980 when the first reports of clinical feline hyperthyroidism (FHT) appeared in the literature, our understanding of the disease has evolved tremendously. Initially, FHT was a disease that only referral clinicians treated. Now it is a disease that primary clinicians routinely manage. Inclusion of the measurement of total thyroxine concentration in senior wellness panels, as well as in diagnostic work-ups for sick cats, now enables diagnosis of the condition long before the cat becomes the classic scrawny, unkempt, agitated patient with a bulge in its neck. However, earlier recognition of the problem has given rise to several related questions: how to recognize the health significance of the early presentations of the disease; how early to treat the disease; whether to treat FHT when comorbid conditions are present; and how to manage comorbid conditions such as chronic kidney disease and cardiac disease with treatment of FHT. The 2016 AAFP Guidelines for the Management of Feline Hyperthyroidism (hereafter referred to as the Guidelines) will shed light on these questions for the general practitioner and suggest when referral may benefit the cat. SCOPE: The Guidelines explain FHT as a primary disease process with compounding factors, and provide a concise explanation of what we know to be true about the etiology and pathogenesis of the disease.The Guidelines also:Distill the current research literature into simple recommendations for testing sequences that will avoid misdiagnosis and separate an FHT diagnosis into six clinical categories with associated management strategies.Emphasize the importance of treating all hyperthyroid cats, regardless of comorbidities, and outline the currently available treatments for the disease.Explain how to monitor the treated cat to help avoid exacerbating comorbid diseases.Dispel some of the myths surrounding certain aspects of FHT and replace them with an evidence-based narrative that veterinarians and their practice teams can apply to feline patients and communicate to their owners. EVIDENCE BASE: To help ensure better case outcomes, the Guidelines reflect currently available, evidenced-based knowledge. If research is lacking, or if a consensus does not exist, the expert panel of authors has made recommendations based on their extensive, cumulative clinical experience.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication: https://pubmed.ncbi.nlm.nih.gov/27143042/